VanEck Biotech ETF
BBH
104 hedge funds and large institutions have $130M invested in VanEck Biotech ETF in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 38 reducing their positions, and 15 closing their positions.
1,174% more call options, than puts
Call options by funds: $2.61M | Put options by funds: $205K
2.36% less ownership
Funds ownership: 37.82% → 35.46% (-2.4%)
10% less funds holding
Funds holding: 115 → 104 (-11)
14% less capital invested
Capital invested by funds: $150M → $130M (-$20.5M)
61% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 38
67% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$680K |
| 2 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$277K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$258K |
| 4 |
Wealthfront Advisers
Palo Alto,
California
|
+$236K |
| 5 |
SFS
Strategic Financial Services
Utica,
New York
|
+$209K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$6.81M |
| 2 |
Goldman Sachs
New York
|
-$2.58M |
| 3 |
Morgan Stanley
New York
|
-$2.38M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$2.26M |
| 5 |
CIG
Consolidated Investment Group
Englewood,
Colorado
|
-$1.82M |
BBH Hedge Fund Activity: Q1 2025 in Review
104 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2025, worth a combined $130M — down 14% from $150M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of BBH and 5 opened new positions — a net loss of 10 holders — while 38 trimmed existing stakes and 15 added.
The largest buyer was Jane Street, opening a new position worth an estimated $680K. The largest seller was Bank of America, cutting an estimated $6.81M.
- 104 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2025, down from 115 in Q4 2024.
- Funds reported $130M of VanEck Biotech ETF stock for Q1 2025, down 14% quarter-over-quarter.
- 5 funds opened new VanEck Biotech ETF positions in Q1 2025 and 15 closed out, a net change of -10 holders.
- The largest VanEck Biotech ETF buyer in Q1 2025 was Jane Street, an estimated $680K added.
- The largest VanEck Biotech ETF seller in Q1 2025 was Bank of America, an estimated $6.81M sold.
Based on aggregated 13F filings for Q1 2025.